| Rob
has a PhD in Inorganic Chemistry from Oxford University,
and has been involved in the Scientific Software and
Informatics industry for the last 12 years. Following
on from an initial career as a software developer with
Oxford Molecular in the UK, Rob has been involved in
the creation and marketing of a number of innovative
software solutions, particularly targeted at the Life
Sciences and Pharma industries. Rob managed the development
of DIVA, an application which enables bench scientists
to analyse highly complex data, in collaboration with
GlaxoWellcome, and was also responsible for the creation
of the prototype for CambridgeSoft's E-Notebook product.
In 2001 Rob co-founded Amedis Pharmaceuticals, focussing
on the development of predictive models for ADMET properties
of molecules. Rob is now head of CambridgeSoft's European
business, and is particularly involved in the E-Notebook
application area. |
